Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Open-market sale Chief Executive Officer sold 8,831 shares at an average $23.89 ($211,005)
  2. 4 Open-market sale Chief Operating Officer sold 8,831 shares at an average $23.89 ($211,005)
  3. 4 Open-market sale President sold 4,857 shares at an average $23.89 ($116,051)
  4. 4 Open-market sale Chief Medical Officer sold 7,065 shares at an average $23.89 ($168,809)
  5. 4 Open-market sale Chief Operating Officer sold 1,044 shares at $24.91 ($26,006)
  6. 4 Grant or award Director acquired 3,000 shares (grant or award)
  7. 4 Grant or award Director acquired 3,000 shares (grant or award)
  8. 4 Grant or award Director acquired 3,000 shares (grant or award)
  9. 4 Grant or award Director acquired 3,000 shares (grant or award)
  10. 4 Grant or award Director acquired 3,000 shares (grant or award)
  11. 4 Grant or award Director acquired 3,000 shares (grant or award)
  12. 4 Open-market buy Director bought 4,133 shares at $31.37 ($129,652)
  13. 4 Open-market sale Chief Medical Officer sold 4,133 shares at $31.37 ($129,652)
  14. 4 Open-market buy Director bought 20,000 shares at $28.35 ($566,996)
  15. 4 Open-market sale Chief Medical Officer sold 2,127 shares at $35.03 ($74,509)
  16. 4 Open-market sale Chief Operating Officer sold 8,661 shares at $35.03 ($303,394)
  17. 4 Gift Chief Executive Officer gave 311,900 shares (gift)
  18. 4 Open-market buy 10% owner bought 5,650,000 shares at $39.00 ($220,350,000)
  19. 4 Grant or award General Counsel acquired 12,538 shares (grant or award)
  20. 4 Grant or award Chief Executive Officer acquired 45,000 shares (grant or award)

Page 10 of 15 · 290 filings